Bongomin, FelixKwizera, RichardMande, EmmanuelAloyo, Sharley MelissaAchan, BeatriceNamusobya, MarthaSereke, Senai GoitomBatte, CharlesKiguli, SarahBaruch Baluku, JosephJoloba, Moses LKirenga, Bruce J2023-11-302023-11-302022-09-03Bongomin, F., Kwizera, R., Mande, E., Aloyo, S. M., Achan, B., Namusobya, M., ... & Kirenga, B. J. (2022). Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda. African Health Sciences, 22(3), 506-511.https://dx.doi.org/10.4314/ahshttps://hdl.handle.net/20.500.14270/401Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with crit ical illness. We investigated the baseline anti-Aspergillus antibody serostatus of patients with moderate-critical COVID-19 hos pitalized at 3 COVID-19 Treatment Units in Uganda. All 46 tested patients, mean age 30, and 11% with underlying respiratory disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom onset (range 1-26), but follow up specimens to assess seroconversion were not available.enInvasive pulmonary aspergillosis,COVID-19,critical illness,UgandaArticle